Novartis AG

(NVS) Trade

By |

Profile

Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Contact Information

Website: www.novartis.com
Email: Investor.relations@novartis.com
Main Phone: +41 613241111
Address: Lichtstrasse 35
City / Town: Basel
Country: CH
Postal Code: 4056

Issuer Information

Exchange: NYE
CEO: Vasant Narasimhan
Employees: 103914
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More

Profile

Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Contact Information

Website: www.novartis.com
Email: Investor.relations@novartis.com
Main Phone: +41 613241111
Address: Lichtstrasse 35
City / Town: Basel
Country: CH
Postal Code: 4056

Issuer Information

Exchange: NYE
CEO: Vasant Narasimhan
Employees: 103914
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
$ 96.69 $ 1.06 (1.11%)
Last Price 96.69 Change $ 1.06 Change % 1.11 Tick N/A
Bid 96.64 Bid Size 300.00 Ask 96.69 Ask Size 1,700.00
Open 96.38 High 96.88 Low 95.85 Prev Close 95.63
Last Trade Volume 2.3 mi 52 Wk Hi 99.85 52 Wk Low 69.19
Market Cap 219.9 bi Ex-Div Date Div Rate 3.09 Yield 3.1930
Shares 2,274,500,000.00 EPS (TTM) 5.28 PE Ratio 30.90 Exchange NYSE
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 98 98 98 98
Low Target Price Estimate 82.3 82.3 82.3 82.3
Mean Target Price Estimate 90.77 90.77 90.77 90.15
Standard Deviation 7.92 7.92 7.92 11.1
Date of Most Recent Estimate 04/23/18 04/23/18 04/23/18 04/23/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 3
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 1 1 1 1
Strong Sell 1 1 1 1
Mean Rec. 2.8 2.8 2.8 2.5